In T2DM uncontrolled with noninsulin glucose-lowering agents, weekly icodec reduced HbA(1c) vs. daily degludec at 26 wk. Belal H, Gandhi GY. Ann Intern Med 2023;176:JC112.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Belal H, Gandhi GY. In T2DM uncontrolled with noninsulin glucose-lowering agents, weekly icodec reduced HbA(1c) vs. daily degludec at 26 wk. Ann Intern Med 2023;176:JC112.
PMID: 37782923